U.S

Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).

This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted.DXVX is taking...

U.S. General Services Administration Renews and Expands Contract with Uber for Business, Modernizing Government Mobility Offerings to Better Serve Federal Employees

US | Jul 16, 2025Written byUber for BusinessThe expanded global transportation and travel program helps consolidate procurement and eliminate the...